You have 9 free searches left this month | for more free features.

ramucirumab

Showing 1 - 25 of 80

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastroesophageal Adenocarcinoma Trial (Paclitaxel, Ramucirumab, Zanidatamab)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • (no location specified)
Sep 12, 2023

Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • TRK-950
  • +2 more
  • Chuo Ku, Japan
    Osaka International Cancer Institute
Sep 14, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial (Ramucirumab, Paclitaxel)

No longer available
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jan 17, 2023

Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

Not yet recruiting
  • Recurrent Head and Neck Cancer
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 30, 2023

Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, other, procedure)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Ramucirumab
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 21, 2022

Non Small Cell Lung Cancer, Metastatic, Recurrent Trial in United States (Lorlatinib, Ramucirumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Middletown, New Jersey
  • +5 more
Aug 17, 2023

Gastric Adenocarcinoma Trial in Guangzhou (Sintilimab, Ramucirumab, Cisplatin)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Oct 10, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • (no location specified)
Jan 9, 2023

Carcinoid Tumors Trial in Boston (Ramucirumab, Somatostatin Analog)

Active, not recruiting
  • Carcinoid Tumors
  • Ramucirumab
  • Somatostatin Analog
  • Boston, Massachusetts
  • +1 more
Apr 14, 2022

Non Small Cell Lung Cancer Trial in Philadelphia (Nivolumab, Ramucirumab)

Recruiting
  • Non Small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Apr 6, 2022

Gastric Adenocarcinoma, Metastatic Adenocarcinoma of the Gastroesophageal Junction Trial in Germany (Ramucirumab, TAS 102)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Metastatic Adenocarcinoma of the Gastroesophageal Junction
  • Ramucirumab
  • TAS 102
  • Frankfurt, Germany
  • +4 more
Mar 2, 2022

NSCLC Trial in Philadelphia (Carboplatin, Paclitaxel, Ramucirumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 14, 2022

NSCLC Stage IB, NSCLC Stage II, NSCLC Stage ?A Trial in Kashiwa, Shinjuku-Ku (Pembrolizumab, Ramucirumab, Surgery)

Recruiting
  • Non-small Cell Lung Cancer Stage IB
  • +2 more
  • Kashiwa, Chiba, Japan
  • +1 more
Apr 4, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 7, 2023

Gastric Cancer, Esophageal Cancer, Gastro-esophageal Cancer Trial in Taiwan, United States (Oraxol, Ramucirumab)

Unknown status
  • Gastric Cancer
  • +2 more
  • San Antonio, Texas
  • +4 more
Feb 15, 2022

Non Small Cell Lung Cancer Trial in Tampa, Houston (quaratusugene ozeplasmid, pembrolizumab, docetaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • quaratusugene ozeplasmid
  • +3 more
  • Tampa, Florida
  • +2 more
Sep 12, 2022

Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Metastatic Non-Small Lung Cell Cancer
  • +4 more
  • Atlanta, Georgia
    Winship Cancer Institute of Emory University
Oct 19, 2022

NSCLC, Non-small Cell Carcinoma, NSCLC Trial (Ramucirumab, Atezolizumab, N-803)

Withdrawn
  • Non-small Cell Lung Cancer
  • +3 more
  • Ramucirumab
  • +2 more
  • (no location specified)
Oct 28, 2021

Pancreatic Cancer Trial in United States (mFOLFIRINOX, Ramucirumab, Placebo)

Active, not recruiting
  • Pancreatic Cancer
  • Scottsdale, Arizona
  • +7 more
Feb 14, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, drug, biological)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Nov 30, 2022

Tumors, Child, Adolescent Trial in Leiden (Ramucirumab, Cyclophosphamide, Vinorelbine)

Recruiting
  • Neoplasms
  • +2 more
  • Ramucirumab
  • +7 more
  • Leiden, Netherlands
    Leids Universitair Medisch Centrum
Aug 14, 2023

Esophagus Cancer, Adenocarcinoma, Stomach Cancer, Adenocarcinoma Trial in United States (Rucaparib, Ramucirumab, Nivolumab)

Recruiting
  • Esophagus Cancer, Adenocarcinoma
  • Stomach Cancer, Adenocarcinoma
  • Chicago, Illinois
  • +7 more
Jan 31, 2022

Advanced Solid Tumor Trial in Japan, United States (Ramucirumab)

Terminated
  • Advanced Solid Tumor
  • Ramucirumab
  • Fayetteville, Arkansas
  • +4 more
Aug 31, 2021

Metastatic Esophageal Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Dallas (Abemaciclib,

Not yet recruiting
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Dallas, Texas
    Baylor University Medical Center, Charles A Sammons Cancer Cente
Jun 4, 2021

Stomach Tumors Trial in Milan (RAMUCIRUMAB, Paclitaxel, FOLFOX 4)

Recruiting
  • Stomach Neoplasms
  • RAMUCIRUMAB
  • +4 more
  • Milan, Italy
    Maria Di Bartolomeo
Sep 3, 2021